Blindness and vision loss impact over 1 billion people around the world. From our first discovery in 1948 at Allergan, now part of AbbVie, see how our scientists are building on a legacy of preserving and protecting vision.
The experiences of these AbbVie leaders are aiming to elevate the standard of care for patients with diabetes and vision complications.
Look at the science behind helping to prevent vision loss and impairment, a leading cause of disability that affects nearly 30% of the world’s population.
Helping patients get to a doctor sooner.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?